FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978679706> ?p ?o ?g. }

• W1978679706 endingPage "476" @default.
• W1978679706 startingPage "467" @default.
• W1978679706 abstract "Osteoblasts and adipocytes are derived from mesenchymal stem cells and play important roles in skeletal homeostasis. Osteoblast differentiation results in a decrease in the cellular concentration of the isoprenoid geranylgeranyl pyrophosphate (GGPP), and the statin-mediated depletion of GGPP stimulates osteoblast differentiation. Adipogenic differentiation, in contrast, results in increased expression of GGPP synthase (GGPPS), and GGPP lowering agents inhibit adipogenesis in vitro. In this study, we tested the hypothesis that GGPP inhibits osteoblast differentiation and enhances adipogenesis. We found that treatment with exogenous GGPP reduced osteoblastic gene expression and matrix mineralization in primary calvarial osteoblast cultures. GGPP treatment of primary calvarial osteoblasts and bone marrow stromal cells (BMSCs) led to increased expression of total peroxisome proliferator activated receptor (PPAR)-γ as well as the adipocyte specific splice variant PPARγ2. Inhibition of PPARγ transcriptional activity did not prevent the effects of GGPP on osteoblasts, suggesting that enhanced PPARγ expression is secondary to the inhibition of osteoblast differentiation. Enhanced PPARγ expression correlated with the increased formation of Oil Red O-positive cells in osteoblast cultures. Additionally, primary calvarial osteoblasts treated with GGPP exhibited increased expression of the adipokine adiponectin. Consistent with a role for GGPP in adipogenesis, adipogenic differentiation of BMSCs could be impaired by specific depletion of cellular GGPP. In contrast to previous reports utilizing other cell types, treatment of osteoblasts with GGPP did not increase geranylgeranylation, suggesting that GGPP itself may be acting as a signaling molecule. GGPP treatment of MC3T3-E1 pre-osteoblasts and primary calvarial osteoblasts led to enhanced insulin-induced Erk signaling which has been previously demonstrated to inhibit insulin receptor substrate (IRS)-1 activity. Additionally, GGPP treatment of MC3T3-E1 pre-osteoblasts resulted in a decrease in the insulin-induced phosphorylation of the insulin receptor. Altogether these findings demonstrate a negative role for GGPP in osteoblast differentiation, leading to increased adipogenesis. Additionally, the effects of GGPP on insulin signaling suggest a potential mechanism for inhibition of osteoblast differentiation and also implicate a role for this isoprenoid in physiological energy homeostasis. This article is part of a Special Issue entitled: Interactions Between Bone, Adipose Tissue and Metabolism." @default.
• W1978679706 created "2016-06-24" @default.
• W1978679706 creator A5051858382 @default.
• W1978679706 creator A5061894336 @default.
• W1978679706 date "2012-02-01" @default.
• W1978679706 modified "2023-09-25" @default.
• W1978679706 title "Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation" @default.
• W1978679706 cites W1949772429 @default.
• W1978679706 cites W1971400919 @default.
• W1978679706 cites W1972401702 @default.
• W1978679706 cites W1980338363 @default.
• W1978679706 cites W1987247016 @default.
• W1978679706 cites W1990792003 @default.
• W1978679706 cites W1992284130 @default.
• W1978679706 cites W2003228453 @default.
• W1978679706 cites W2009709078 @default.
• W1978679706 cites W2012459203 @default.
• W1978679706 cites W2013339414 @default.
• W1978679706 cites W2019265270 @default.
• W1978679706 cites W2020364703 @default.
• W1978679706 cites W2021438186 @default.
• W1978679706 cites W2024941123 @default.
• W1978679706 cites W2027484665 @default.
• W1978679706 cites W2032643735 @default.
• W1978679706 cites W2036796720 @default.
• W1978679706 cites W2040275316 @default.
• W1978679706 cites W2049855386 @default.
• W1978679706 cites W2050834166 @default.
• W1978679706 cites W2053770173 @default.
• W1978679706 cites W2059826496 @default.
• W1978679706 cites W2066781262 @default.
• W1978679706 cites W2071124826 @default.
• W1978679706 cites W2071283128 @default.
• W1978679706 cites W2072009880 @default.
• W1978679706 cites W2077202113 @default.
• W1978679706 cites W2088730128 @default.
• W1978679706 cites W2089687829 @default.
• W1978679706 cites W2093416757 @default.
• W1978679706 cites W2096738462 @default.
• W1978679706 cites W2097511872 @default.
• W1978679706 cites W2098586364 @default.
• W1978679706 cites W2100391645 @default.
• W1978679706 cites W2114419613 @default.
• W1978679706 cites W2122986651 @default.
• W1978679706 cites W2135176380 @default.
• W1978679706 cites W2157388990 @default.
• W1978679706 cites W2159999899 @default.
• W1978679706 cites W2176744910 @default.
• W1978679706 cites W4237568731 @default.
• W1978679706 cites W4320800126 @default.
• W1978679706 doi "https://doi.org/10.1016/j.bone.2011.09.056" @default.
• W1978679706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22019459" @default.
• W1978679706 hasPublicationYear "2012" @default.
• W1978679706 type Work @default.
• W1978679706 sameAs 1978679706 @default.
• W1978679706 citedByCount "21" @default.
• W1978679706 countsByYear W19786797062012 @default.
• W1978679706 countsByYear W19786797062013 @default.
• W1978679706 countsByYear W19786797062014 @default.
• W1978679706 countsByYear W19786797062015 @default.
• W1978679706 countsByYear W19786797062016 @default.
• W1978679706 countsByYear W19786797062017 @default.
• W1978679706 countsByYear W19786797062018 @default.
• W1978679706 countsByYear W19786797062020 @default.
• W1978679706 crossrefType "journal-article" @default.
• W1978679706 hasAuthorship W1978679706A5051858382 @default.
• W1978679706 hasAuthorship W1978679706A5061894336 @default.
• W1978679706 hasConcept C104317684 @default.
• W1978679706 hasConcept C122927707 @default.
• W1978679706 hasConcept C126322002 @default.
• W1978679706 hasConcept C134018914 @default.
• W1978679706 hasConcept C148738053 @default.
• W1978679706 hasConcept C181199279 @default.
• W1978679706 hasConcept C198826908 @default.
• W1978679706 hasConcept C202751555 @default.
• W1978679706 hasConcept C2778260815 @default.
• W1978679706 hasConcept C2778827360 @default.
• W1978679706 hasConcept C55493867 @default.
• W1978679706 hasConcept C57790582 @default.
• W1978679706 hasConcept C71924100 @default.
• W1978679706 hasConcept C86803240 @default.
• W1978679706 hasConcept C95444343 @default.
• W1978679706 hasConceptScore W1978679706C104317684 @default.
• W1978679706 hasConceptScore W1978679706C122927707 @default.
• W1978679706 hasConceptScore W1978679706C126322002 @default.
• W1978679706 hasConceptScore W1978679706C134018914 @default.
• W1978679706 hasConceptScore W1978679706C148738053 @default.
• W1978679706 hasConceptScore W1978679706C181199279 @default.
• W1978679706 hasConceptScore W1978679706C198826908 @default.
• W1978679706 hasConceptScore W1978679706C202751555 @default.
• W1978679706 hasConceptScore W1978679706C2778260815 @default.
• W1978679706 hasConceptScore W1978679706C2778827360 @default.
• W1978679706 hasConceptScore W1978679706C55493867 @default.
• W1978679706 hasConceptScore W1978679706C57790582 @default.
• W1978679706 hasConceptScore W1978679706C71924100 @default.
• W1978679706 hasConceptScore W1978679706C86803240 @default.
• W1978679706 hasConceptScore W1978679706C95444343 @default.
• W1978679706 hasFunder F4320306274 @default.

• next